SCHEDULE 13G/A
SCHEDULE 13G/ASchedule 13G ownership disclosure
Protagonist Therapeutics Inc
Common Stock, par value $0.00001 per share (the "Shares") · CUSIP: 74366E102
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Farallon Capital Partners, L.P.
Shares: 283,062 · Class: 0.5%
- Farallon Capital Institutional Partners, L.P.
Shares: 290,850 · Class: 0.5%
- Farallon Capital Institutional Partners II, L.P.
Shares: 91,421 · Class: 0.1%
- Farallon Capital Institutional Partners III, L.P.
Shares: 39,417 · Class: 0.1%
- Four Crossings Institutional Partners V, L.P.
Shares: 53,343 · Class: 0.1%
- Farallon Capital Offshore Investors II, L.P.
Shares: 565,080 · Class: 0.9%
- Farallon Capital (AM) Investors, L.P.
Shares: 36,181 · Class: 0.1%
- Farallon Capital F5 Master I, L.P.
Shares: 121,094 · Class: 0.2%
- Farallon Healthcare Partners Master, L.P.
Shares: 4,767,564 · Class: 7.6%
- Farallon Partners, L.L.C.
Shares: 6,126,919 · Class: 9.8%
- Farallon Institutional (GP) V, L.L.C.
Shares: 53,343 · Class: 0.1%
- Farallon F5 (GP), L.L.C.
Shares: 121,094 · Class: 0.2%
- Farallon Healthcare Partners (GP), L.L.C.
Shares: 4,767,564 · Class: 7.6%
- Dapice Joshua J.
Shares: 6,248,013 · Class: 9.99%
- Dreyfuss, Philip D.
Shares: 6,248,013 · Class: 9.99%
- Dunn Hannah E.
Shares: 6,248,013 · Class: 9.99%
- Fried, Richard B
Shares: 0 · Class: 0%
- Gehani, Varun N.
Shares: 6,248,013 · Class: 9.99%
- Giauque, Nicolas
Shares: 6,248,013 · Class: 9.99%
- Husen, Avner A.
Shares: 6,248,013 · Class: 9.99%
- Kim, David T.
Shares: 6,248,013 · Class: 9.99%
- Linn, Michael G.
Shares: 6,248,013 · Class: 9.99%
- Luo Patrick (Cheng)
Shares: 6,248,013 · Class: 9.99%
- Patel, Rajiv A.
Shares: 0 · Class: 0%
- Roberts, Jr., Thomas G.
Shares: 6,248,013 · Class: 9.99%
- Saito Edric C.
Shares: 6,248,013 · Class: 9.99%
- Seybold, William
Shares: 0 · Class: 0%
- Short Daniel S.
Shares: 6,248,013 · Class: 9.99%
- Spokes, Andrew J. M.
Shares: 6,248,013 · Class: 9.99%
- Warren, John R.
Shares: 6,248,013 · Class: 9.99%
- Wehrly, Mark C.
Shares: 6,248,013 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000908834-26-000054
- Form type
- SCHEDULE 13G/A
- Filer
- Farallon Capital Partners, L.P.
- CIK
- CIK 1175707
- Filed
- Feb 06, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership